Literature DB >> 19889938

Use of a baculovirus-expressed structural protein for the detection of antibodies to foot-and-mouth disease virus type A by a blocking enzyme-linked immunosorbent assay.

Young-Joon Ko1, Hyang-Sim Lee, Hye-Young Jeoung, Eun-Jeong Heo, Hyo-Rim Ko, Byung-Sik Chang, Hoo-Don Joo, U Gerelmaa, B Dashzeveg, S Tserendorj, R Sodnomdarjaa, Jong-Hyeon Park, Chang-Hee Kweon, In-Soo Cho, Sang-Gi Paik.   

Abstract

A blocking enzyme-linked immunosorbent assay (ELISA) with a baculovirus-expressed structural protein was developed for the detection of antibodies to foot-and-mouth disease virus type A. It exhibited 99% specificity with a cutoff of 53% inhibition. Its sensitivity was comparable to the sensitivities of the virus neutralization test and the liquid-phase blocking ELISA, indicating its potential as an alternative assay.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19889938      PMCID： PMC2812095          DOI： 10.1128/CVI.00374-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  25 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.

Authors:  R Acharya; E Fry; D Stuart; G Fox; D Rowlands; F Brown
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

3.  A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA.

Authors:  C Hamblin; I T Barnett; R S Hedger
Journal:  J Immunol Methods       Date:  1986-10-23       Impact factor: 2.303

4.  Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina.

Authors:  B Robiolo; P R Grigera; O H Periolo; C Seki; T Bianchi; E Maradei; J L La Torre
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

5.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.

Authors:  J L Bittle; R A Houghten; H Alexander; T M Shinnick; J G Sutcliffe; R A Lerner; D J Rowlands; F Brown
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

6.  A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology.

Authors:  Gilles Chénard; Kor Miedema; Peter Moonen; Remco S Schrijver; Aldo Dekker
Journal:  J Virol Methods       Date:  2003-01       Impact factor: 2.014

7.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

Review 8.  Molecular epidemiology of foot-and-mouth disease virus.

Authors:  N J Knowles; A R Samuel
Journal:  Virus Res       Date:  2003-01       Impact factor: 3.303

9.  Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.

Authors:  E Pfaff; M Mussgay; H O Böhm; G E Schulz; H Schaller
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

Review 10.  Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure.

Authors:  G J Belsham
Journal:  Prog Biophys Mol Biol       Date:  1993       Impact factor: 3.667
View more
  3 in total

1.  Development of an Indirect Chemiluminescence Immunoassay Using a Multiepitope Recombinant Protein To Specifically Detect Antibodies against Foot-and-Mouth Disease Virus Serotype O in Swine.

Authors:  Wei Liu; Junjun Shao; Guanglei Zhang; Yanyan Chang; Sudan Ge; Yue Sun; Zhan Gao; Huiyun Chang
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

2.  Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis.

Authors:  Ming Yang; Wanhong Xu; Hilary Bittner; Jacquelyn Horsington; Wilna Vosloo; Melissa Goolia; Diana Lusansky; Charles Nfon
Journal:  Virol J       Date:  2016-11-28       Impact factor: 4.099

3.  Production of foot-and-mouth disease virus SAT2 VP1 protein.

Authors:  Mpho Victoria Mamabolo; Jacques Theron; Francois Maree; Michael Crampton
Journal:  AMB Express       Date:  2020-01-07       Impact factor: 3.298
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.